← Leaderboards
Raymond G Booth
University Of North Carolina Chapel Hill
$7,498,592
Attributed
$10,360,327
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,360,327 · 7
By mechanism
R01$9,023,484 · 5
T32$1,229,796 · 1
R29$107,047 · 1
Top collaborators
- Stephen John Kohut5 shared
- Alexandros Makriyannis4 shared
- Carol A Paronis4 shared
- Drake Morgan3 shared
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAnalogBaseMolecularStructureReceptorAffinityAgonistIn VivoAttenuationIn VitroSerotoninPharmacotherapyBehaviorRecombinantsLigandsMolecular ConformationBinding (Molecular Function)Molecular ModelingCellsBrainNeuropsychiatryDesignPeripheral
Grant awards (30)
Training Program on Development of Medications for Substance Use Disorder$347,268
T32 · FY2025 · DA
Training Program on Development of Medications for Substance Use Disorder$224,689
T32 · FY2024 · DA
Training Program on Development of Medications for Substance Use Disorder$339,036
T32 · FY2023 · DA
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders: Development of novel 5-HT2 modulators with translational studies in rodents and primates$613,134
R01 · FY2022 · DA · contact PI
Training Program on Development of Medications for Substance Use Disorder$318,803
T32 · FY2022 · DA
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimates$606,215
R01 · FY2021 · DA · contact PI
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimates$613,647
R01 · FY2020 · DA · contact PI
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimates$625,576
R01 · FY2019 · DA · contact PI
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimates$694,722
R01 · FY2018 · DA · contact PI
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder$309,794
R01 · FY2014 · DA · contact PI
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder$297,402
R01 · FY2013 · DA · contact PI
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist Activity$330,983
R01 · FY2012 · MH · contact PI
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder$323,253
R01 · FY2012 · DA · contact PI
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist Activity$45,633
R01 · FY2012 · MH · contact PI
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder$350,426
R01 · FY2011 · DA · contact PI
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist Activity$325,006
R01 · FY2011 · MH · contact PI
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder$360,403
R01 · FY2010 · DA · contact PI
Novel 5HT2C Agonist Drugs with 5HT2A Antagonist Activity for Cocaine Addiction$349,949
R01 · FY2010 · DA · contact PI
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist Activity$329,100
R01 · FY2010 · MH · contact PI
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist Activity$403,057
R01 · FY2009 · MH · contact PI
Novel 5HT2C Agonist Drugs with 5HT2A Antagonist Activity for Cocaine Addiction$354,194
R01 · FY2009 · DA · contact PI
Novel 5HT2C Agonist Drugs with 5HT2A Antagonist Activity for Cocaine Addiction$91,563
R01 · FY2009 · DA · contact PI
Novel 5HT2C Agonist Drugs with 5HT2A Antagonist Activity for Cocaine Addiction$354,811
R01 · FY2008 · DA · contact PI
Serotonin 5HT2C Agonist Drugs with 5HT2A/2B Antagonist Activity$342,526
R01 · FY2008 · MH · contact PI
Novel 5HT2C Agonist Drugs with 5HT2A Antagonist Activity for Cocaine Addiction$362,599
R01 · FY2007 · DA · contact PI
FUNCTIONAL PROBES FOR BRAIN HISTAMINE H1 RECEPTORS$222,424
R01 · FY2007 · MH · contact PI
FUNCTIONAL PROBES FOR BRAIN HISTAMINE H1 RECEPTORS$232,722
R01 · FY2006 · MH · contact PI
FUNCTIONAL PROBES FOR BRAIN HISTAMINE H1 RECEPTORS$234,782
R01 · FY2005 · MH
FUNCTIONAL PROBES FOR BRAIN HISTAMINE H1 RECEPTORS$249,563
R01 · FY2004 · MH
NOVEL SIGMA RECEPTOR LIGANDS IN NEURODEGENERATION$107,047
R29 · FY2000 · NS